A nationwide study on the impact of pneumococcal conjugate vaccination on antibiotic use and ventilation tube insertion in Denmark 2000–2014

Vaccine

Volumn 35, Issue 43, 2017, Pages 5858-5863

  Howitz, Michael Frantz ^a   Harboe, Zitta Barrella ^b,c   Ingels, Helene ^d   Valentiner Branth, Palle ^b   Mølbak, Kåre ^b   Djurhuus, Bjarki Ditlev ^e,f  

^a HILLERØD HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c Rigshospitalet   (Denmark)

^d NAESTVED HOSPITAL   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^f ZEALAND UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antibiotic; PCV13; PCV7; Upper respiratory diseases; Ventilation tube insertion; VTI

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE; ANTIINFECTIVE AGENT; VACCINE;

ADOLESCENT; ARTICLE; CHILD; DENMARK; DRUG USE; GROUPS BY AGE; HUMAN; INCIDENCE; INFANT; OBSERVATIONAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SCHOOL CHILD; TREND STUDY; VACCINATION; VENTILATION TUBE INSERTION; IMMUNOLOGY; NEWBORN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PROCEDURES; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DENMARK; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; INFANT, NEWBORN; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 85029504169     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.09.006     Document Type: Article

References (35)

1. O'Brien, K.L., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet Lond Engl 374 (2009), 893–902.
2. Valentiner-Branth P et al. “Pneumococcal vaccine in childhood vaccination programme”. Statens Serum Institut, Epi-News 37a, 2007; 2007.
3. Valentiner-Branth P et al. “PCV coverage & invasive pneumococcal disease 2011”. Statens Serum Institut, Epi-News 21/2012.
4. Harboe, Z.B., et al. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis Off Publ Infect Dis Soc Am 59:8 (2014), 1066–1073.
5. Petit, G., et al. Epidemiological and economic burden of pneumococcal diseases in Canadian children. Can J Infect Dis J Can Mal Infect 14:4 (2003), 215–220.
6. Fortanier, A.C., et al. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev, 4, 2014.
7. Groth, C., Thomsen, R.W., Ovesen, T., Association of pneumococcal conjugate vaccination with rates of ventilation tube insertion in Denmark: population-based register study. BMJ Open, 5(6), 2015, e007151.
8. “StatBank Denmark. Statistics Denmark.” Statistics Denmark, 2015.
9. Christiansen A, Bang H, Vestergaard L, Andersen P, Jørgensen B, Ravsbæk Bode R. Invasive pneumococcal disease and coverage of pneumococcal vaccination in the childhood vaccination programme 2015. Statens Serum Institut, Epi-news 40/2016.
10. “Highlights on Health in Denmark 2004”. World Health Organization Regional Office for Europe, 2006.
11. Kildemoes, H.W., Sorensen, H.T., Hallas, J., The Danish national prescription registry. Scand J Public Health 39:7 Suppl (2011), 38–41.
12. “Own calculations based on numbers from medstat.dk.” Sundhedsdatastyrelsen, 2015.
13. Sônksen U et al. “DANMAP 2014,” Statens Serum Institut, Epi-news 42/43 2015.
14. Andersen, J.S., Olivarius, N.D.F., Krasnik, A., The Danish national health service register. Scand J Public Health 39:7 Suppl (2011), 34–37.
15. Djurhuus, B.D., Skytthe, A., Christensen, K., Faber, C.E., Increasing rate of middle ear ventilation tube insertion in children in Denmark. Int J Pediatr Otorhinolaryngol 78:9 (2014), 1541–1544.
16. Committee, The Nordic Medico-Statistical, NOMESCO classification for surgical procedures. 2005, Munksgaard, Copenhagen.
17. Lynge, E., Sandegaard, J.L., Rebolj, M., The Danish national patient register. Scand J Public Health 39:7 Suppl (2011), 30–33.
18. Djurhuus, B.D., Skytthe, A., Faber, C.E., Validation of the cholesteatoma diagnosis in the Danish national hospital register. Dan Med Bull, 57(10), 2010.
19. Ahmad, O.B.-P., Lopez, A., Murray, C., Lozano, R., Inoue, M., Age standardization of rates: a new WHO standard. 2001, World Health Organization.
20. Fireman, B., Black, S.B., Shinefield, H.R., Lee, J., Lewis, E., Ray, P., Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 22:1 (2003), 10–16.
21. McCaig, L.F., Besser, R.E., Hughes, J.M., Trends in antimicrobial prescribing rates for children and adolescents. JAMA 287:23 (2002), 3096–3102.
22. Lau, W.C.Y., et al. Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom. Vaccine 33:39 (2015), 5072–5079.
23. Cohen, R., et al. A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation. Vaccine 33:39 (2015), 5118–5126.
24. Poehling, K.A., et al. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics 119:4 (Apr 2007), 707–715.
25. Jardine, A., Menzies, R.I., Deeks, S.L., Patel, M.S., McIntyre, P.B., The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia. Pediatr Infect Dis J 28:9 (Sep 2009), 761–765.
26. Marom, T., Tan, A., Wilkinson, G.S., Pierson, K.S., Freeman, J.L., Chonmaitree, T., Trends in otitis media-related health care use in the United States, 2001–2011. JAMA Pediatr 168:1 (2014), 68–75.
27. Heidemann, C.H., Lauridsen, H.H., Kjeldsen, A.D., Faber, C.E., Johansen, E.C.J., Godballe, C., Caregiver quality of life and daily functioning in relation to ventilating tube treatment. Otolaryngol–Head Neck Surg Off J Am Acad Otolaryngol–Head Neck Surg 151:2 (2014), 341–347.
28. Harboe, Z.B., Slotved, H.-C., Konradsen, H.B., Kaltoft, M.S., A Pneumococcal carriage study in Danish pre-school children before the introduction of pneumococcal conjugate vaccination. Open Microbiol J 6 (2012), 40–44.
29. Mills, N., et al. What is behind the ear drum? The microbiology of otitis media and the nasopharyngeal flora in children in the era of pneumococcal vaccination. J Paediatr Child Health 51:3 (2015), 300–306.
30. Htar, M. Tin Tin, Christopoulou, D., Schmitt, H.J., Pneumococcal serotype evolution in Western Europe. BMC Infect Dis, 15, 2015, 419.
31. Mølbak, K., et al. Burden of illness of the 2009 pandemic of influenza A (H1N1) in Denmark. Vaccine 29:Suppl 2 (2011), B63–69.
32. Hammerum A et al. “DANMAP 2011: Antimicrobial consumption and resistance”. Statens Serum Institut; 2012.
33. Emborg HD, Krause TG, Voldstedlund M, Uldum SA. “Mycoplasma pneumoniae epidemic”. Statens Serum Institut, Copenhagen, 41/2016.
34. Sundhedsstyrelsen, “NKR: Mellemørebetændelse og behandling med trommehindedræn”. National Health Agency; 2015.
35. World Health Organisation. “The WHO essential medicines and health products information portal”. [Online]. Available: < http://apps.who.int/medicinedocs/en/d/Js4876e/7.1.html> [accessed: 05-Jun-2017].